gilmoreDr. Mike Gilmore is the Sir William Osler Professor of Ophthalmology, and Microbiology and Immunobiology at Harvard Medical School. Dr. Gilmore is the director of the Harvard-wide Program on Antibiotic Resistance, and his research focuses on the evolution and development of multidrug resistant strains of enterococci, staphylococci, and streptococci. The world is facing a serious health crisis with the increasing prevalence of multidrug resistant superbugs; the CDC estimates that there are 2 million infections and 23,000 deaths each year in the U.S. due to antibiotic resistant bacteria.  Dr. Gilmore discusses how bacteria become resistant to antibiotics, what scientists are doing to address this problem, and what everyone can do to help alleviate this impending global health crisis.

Discussants (in alphabetical order):
Dr. Karl Klose (Professor and director of STCEID, UTSA)
Dr. Janakiram Seshu (Associate professor, STCEID,  UTSA)
Dr. Floyd Wormley (Professor, STCEID, UTSA)

chenDr. Wangxue Chen is a research scientist at the National Research Council of Canada. Dr. Chen’s research focuses on vaccine developme against various bacterial pathogens, including Francisella tularensis. This bug is normally found in rabbits, but it is considered one of the most dangerous bacteria because if it gets into your lungs, it can lead to a fatal disease.  It was developed into a bioweapon by a number of countries, and has to be worked on under high-level biocontainment (BSL3) conditions. Dr. Chen discusses what makes particular organisms biothreats, and how scientists are trying to come up with vaccines and other therapies to neutralize these scary bugs.

Discussants (in alphabetical order):
Dr. Neal Guentzel (Professor and Parliamentarian of STCEID, UTSA)

Dr. Karl Klose (Professor and Director of STCEID,  UTSA)

kerns-pic1Dr. Timothy Kern is a professor in the Department of Pharmacology at Case Western Reserve University and director of the Center for Diabetes Research. His research is focused primarily on determining what causes retinopathy in diabetes patients and how to prevent it. His laboratory is identifying how hyperglycemia causes retinopathy, and discovering new treatments that may inhibit the loss of vision in diabetes. In this episode, he talks about how to control blood sugar, new diabetes treatments, and what keeps him working long hours in the lab.

Discussants (in alphabetical order):
Dr. Astrid Cardona (Associate Professor, STCEID, UTSA)
Dr. Janakiram Seshu (Associate Professor, STCEID, UTSA)



mcgeachy3 Dr. Mandy McGeachy is assistant professor of medicine at University of Pittsburgh.  In this episode, she discusses autoimmune diseases. The immune system is designed to protect us from invading microbes and in most of us it does a fantastic job of preventing us from getting sick for most of our lives. However, sometimes this protective shield can turn against us, and when this happens it is referred to as autoimmune disease.  Dr. McGeachy discusses autoimmune diseases such as multiple sclerosis and rheumatoid arthritis: what causes the good guys (our immune system) to go bad?   She talks about one particular component of the immune system that is the focus of her research, Th17 cells, and how these cells play an important role in autoimmune disease. Dr. McGeachy also shares her thoughts about how to balance work and life as a professional woman.

Discussants (in alphabetical order):
Dr. Thomas Forsthuber (Professor, STCEID, UTSA)
Dr. Karl Klose (Professor and Director of STCEID,  UTSA)
Dr. Julie Schwartz (Postdoctoral Fellow, STCEID, UTSA)